PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.54%
Negative revenue growth while ADI stands at 2.31%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.90%
Negative gross profit growth while ADI is at 2.26%. Joel Greenblatt would examine cost competitiveness or demand decline.
-38.53%
Negative EBIT growth while ADI is at 15.58%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-38.53%
Negative operating income growth while ADI is at 15.58%. Joel Greenblatt would press for urgent turnaround measures.
-413.30%
Negative net income growth while ADI stands at 10.69%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-427.27%
Negative EPS growth while ADI is at 6.67%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-427.27%
Negative diluted EPS growth while ADI is at 15.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-4.63%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-4.63%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
3.93%
Dividend growth of 3.93% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
31.68%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
71.62%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
-5.13%
Negative 10Y revenue/share CAGR while ADI stands at 127.71%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-15.47%
Negative 5Y CAGR while ADI stands at 21.55%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-15.91%
Negative 3Y CAGR while ADI stands at 1.70%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
85.67%
10Y OCF/share CAGR at 75-90% of ADI's 96.21%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
50.12%
Positive OCF/share growth while ADI is negative. John Neff might see a comparative advantage in operational cash viability.
-19.16%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-771.93%
Negative 10Y net income/share CAGR while ADI is at 269.32%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-97.66%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-236.55%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
384.28%
10Y equity/share CAGR at 75-90% of ADI's 474.99%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
73.59%
5Y equity/share CAGR at 50-75% of ADI's 136.36%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
22.61%
Below 50% of ADI's 72.64%. Michael Burry suspects a serious short-term disadvantage in building book value.
31.76%
Dividend/share CAGR of 31.76% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
1.27%
Dividend/share CAGR of 1.27% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
11.94%
3Y dividend/share CAGR of 11.94% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-19.03%
Firm’s AR is declining while ADI shows 2.25%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-4.01%
Inventory is declining while ADI stands at 7.87%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.48%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.47%
Positive BV/share change while ADI is negative. John Neff sees a clear edge over a competitor losing equity.
No Data
No Data available this quarter, please select a different quarter.
-0.72%
Our R&D shrinks while ADI invests at 2.11%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-6.80%
We cut SG&A while ADI invests at 3.08%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.